Takeda Begins Japan Trials Of Mood, Anxiety Drugs From Denmark
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals says it has begun trials of the first of two drugs licensed from H. Lundbeck of Denmark to treat mood and anxiety disorders. As LuAA21004, the first of the two drugs, enters trials, Takeda plans to develop LuAA24530. The drugs have differing molecular structures and are intended to be sold along side each other. Both drugs are well into Phase II trials in Europe. (Click here for more - a subscription may be required